Clinical Trials Directory

Trials / Unknown

UnknownNCT01778829

Non Invasive Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants.

Nasal Intermittent Mandatory Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants of the NEOCOSUR Network.

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Pontificia Universidad Catolica de Chile · Academic / Other
Sex
All
Age
2 Hours – 14 Days
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Nasal intermittent positive pressure ventilation (NIPPV) non synchronized is better than continuous positive airway pressure (NCPAP)in preventing extubation failure within 72 h, after extubation of very low birth weight infants at the NEOCOSUR Network.

Detailed description

Is a Randomized trial to preterms infants \<1500g and less than 34 weeks with RDS requiring machanical ventilation in the extubation period, randomized to receive NIPPV or NCPAP once extubation criteria were met. Parental written informed consent is required previous extubation. The failure rate is defined as the need for re-intubation and mechanical ventilation). Exclusion criteria are: major congenital anomalies; presence of cardiovascular instability;intubation less than 2 hours; mechanical ventilation more than 14 days, using muscle relaxant, airway anomalies, consent not provided or refused. Outcome measures: The primary outcome was to assess the need for re-intubation within the first 72 hours after extubation in the 2 groups. The criteria for failure were met by at least 1 of the following: pH \< 7.25 and PaCO2 \> 65 mmHg; recurrent apnea more than 2 episodes per hour associated with bradycardia; during 4 hour continuous; 2 episodes of apnea that required bagand-mask ventilation in any time during the study; or a PaO2 \< 50 mm Hg with a fraction of inspired oxygen \> 0.6. The secondary outcomes concerning respiratory support were total duration on ETT ventilation, total duration on NCPAP, total duration on supplemental oxygen, incidence of pneumothorax,BPD and dead. Other outcomes included incidence of patent ductus arteriosus (PDA), necrotizing enterocolitis, intraventricular hemorrhage grades 3 and 4, retinopathy of prematurity stage 3, time to full feeds, and length of hospital stay. Sample size calculations for the primary outcome: We estimated that there would be a more than 80% chance of detecting 43% difference between the groups (alpha 0.05) when samplesize (n) is 110 patients for each mode of treatment.

Conditions

Interventions

TypeNameDescription
PROCEDURECPAP ventilation modePatients are ventilated through a nasal prong coneected to a ventilator that provides a continuous positive airway pressure
PROCEDURENIPPV ventilation modePatients are ventilated through a nasal prong connected to a ventilator that provides a non synchronized intermittent positive pressure ventilation

Timeline

Start date
2011-12-01
Primary completion
2013-05-01
Completion
2013-06-01
First posted
2013-01-29
Last updated
2013-01-29

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT01778829. Inclusion in this directory is not an endorsement.